Antidepressant + Aripiprazole

DRUG3 trials

Sponsors

Otsuka Pharmaceutical Development & Commercialization, Inc., Bristol-Myers Squibb

Conditions

Major Depressive Disorder

Phase 3

A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder

CompletedNCT00095745

Otsuka Pharmaceutical Development & Commercialization, Inc.Major Depressive Disorder

Start: 2004-09-30End: 2007-11-30Updated: 2013-11-08

A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder

CompletedNCT00095823

Bristol-Myers SquibbMajor Depressive Disorder

Start: 2004-06-30End: 2006-08-31Target: 1200Updated: 2013-11-25

A Study of Adjunctive Aripiprazole in Participants With Major Depressive Disorder

CompletedNCT00095758

Otsuka Pharmaceutical Development & Commercialization, Inc.Major Depressive Disorder

Start: 2004-09-01End: 2006-12-01Updated: 2026-07-13

Related Papers

Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.

2014-07-1815 citations

Effect of symptom severity on efficacy and safety of aripiprazole adjunctive to antidepressant monotherapy in major depressive disorder: A pooled analysis

Journal of Affective Disorders2014-03-2416 citations

Improvement in functional outcomes with adjunctive aripiprazole versus placebo in major depressive disorder: a pooled post hoc analysis of 3 short-term studies.

2012-12-203 citations

Beneficial effects of adjunctive aripiprazole in major depressive disorder are not dependent on antidepressant therapy history: a post hoc analysis of 3 randomized, double-blind, placebo-controlled trials.

2012-11-222 citations

Efficacy of adjunctive aripiprazole in major depressive disorder: a pooled response quartile analysis and the predictive value of week 2 early response.

2012-05-314 citations

Effects of adjunctive aripiprazole on sexual functioning in patients with major depressive disorder and an inadequate response to standard antidepressant monotherapy: a post hoc analysis of 3 randomized, double-blind, placebo-controlled studies.

2011-01-0111 citations

Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder.

2010-08-247 citations

Safety and Tolerability of Adjunctive Aripiprazole in Major Depressive Disorder: A Pooled Post Hoc Analysis (studies CN138-139 and CN138-163).

2009-01-0118 citations

Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.

2008-12-0236 citations

Examining the efficacy of adjunctive aripiprazole in major depressive disorder: a pooled analysis of 2 studies.

2008-01-0130 citations

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

2007-06-01259 citations